2012
DOI: 10.1016/j.tet.2011.11.040
|View full text |Cite
|
Sign up to set email alerts
|

An efficient microwave-assisted synthesis and biological properties of polysubstituted pyrimidinyl- and 1,3,5-triazinylphosphonic acids

Abstract: a b s t r a c tPolysubstituted pyrimidinylphosphonic and 1,3,5-triazinylphosphonic acids with potential biological properties were prepared in high yields by the microwave-assisted MichaeliseArbuzov reaction of trialkyl phosphite with the corresponding halopyrimidines and halo-1,3,5-triazines, respectively, followed by the standard deprotection of the phosphonate group using TMSBr in acetonitrile. 4,6-Diamino-5chloropyrimidin-2-ylphosphonic acid (7a) was found to exhibit a weak to moderate anti-influenza activ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
12
0

Year Published

2014
2014
2021
2021

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 33 publications
0
12
0
Order By: Relevance
“…There is a large class of pharmacologically important pyrimidine derivatives that act as dihydrofolate reductase (DHFR) inhibitors (Hitchings, 1989), as well as compounds with anti-HIV (Holý, 2003;De Clercq and Holý, 2005), anti-adenovirus (Naesens et al, 2005), and anti-HBV activities (Ying et al, 2005), inhibitors of tetrahydrobiopterin synthesis Kolinsky and Gross, 2004), regulators of pain sensitivity and persistence (Tegeder et al, 2006), antidepressants (Arvanitis et al, 1999), compounds which suppress accumulation of cytokine-induced NF-jB (Ikemoto et al, 2008), inhibitors of EGFR and Her-2 tyrosine kinases (Suzuki et al, 2012) and cyclin-dependent kinases as potential drug candidates for cancer therapy (Beattie et al, 2003;Breault et al, 2003). Substitution at position 5 of the pyrimidine moiety has been used in the past to improve the biological property of several pharmacologically interesting pyrimidine derivatives with anti-HIV (Hocková et al, 2003(Hocková et al, , 2004 or anti-influenza activity (Jansa et al, 2012), with inhibitory activity against human thymidine phosphorylase (Nencka et al, 2007) or with antioxidative activity (Procházková et al, 2012a, b).…”
Section: Introductionmentioning
confidence: 99%
“…There is a large class of pharmacologically important pyrimidine derivatives that act as dihydrofolate reductase (DHFR) inhibitors (Hitchings, 1989), as well as compounds with anti-HIV (Holý, 2003;De Clercq and Holý, 2005), anti-adenovirus (Naesens et al, 2005), and anti-HBV activities (Ying et al, 2005), inhibitors of tetrahydrobiopterin synthesis Kolinsky and Gross, 2004), regulators of pain sensitivity and persistence (Tegeder et al, 2006), antidepressants (Arvanitis et al, 1999), compounds which suppress accumulation of cytokine-induced NF-jB (Ikemoto et al, 2008), inhibitors of EGFR and Her-2 tyrosine kinases (Suzuki et al, 2012) and cyclin-dependent kinases as potential drug candidates for cancer therapy (Beattie et al, 2003;Breault et al, 2003). Substitution at position 5 of the pyrimidine moiety has been used in the past to improve the biological property of several pharmacologically interesting pyrimidine derivatives with anti-HIV (Hocková et al, 2003(Hocková et al, , 2004 or anti-influenza activity (Jansa et al, 2012), with inhibitory activity against human thymidine phosphorylase (Nencka et al, 2007) or with antioxidative activity (Procházková et al, 2012a, b).…”
Section: Introductionmentioning
confidence: 99%
“…Most often, the hydrolyses were performed under acidic conditions [ 1 , 2 , 3 , 4 ], but the application of NaOH or KOH is also common [ 5 , 6 , 7 , 8 ]. An additional possibility is the fission of the P-O-C unit by the effect of Me 3 SiBr [ 9 , 10 , 11 ]. Usually, the acid- or base-catalyzed hydrolyses were carried out routinely, under “excessive” (unoptimized) conditions applying the acid or base catalysts in a larger quantity than required, and allowing longer reaction times.…”
Section: Introductionmentioning
confidence: 99%
“…Despite the wide variety of thiazolopyrimidines reported to date, phosphonylated analogues of compounds of this series are unknown. Of special interest is the design of molecules containing practically significant heteroaromatic rings and a biologically active and hydrolysis-resistant phosphonate group, as it has been reported that the combination of several pharmacophore fragments in one molecule can lead to a synergistic increase in biological activity or an additional variety of the latter [22][23][24][25][26][27][28].…”
Section: Introductionmentioning
confidence: 99%